Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib
Titel:
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib
Auteur:
Reichardt, P. Blay, J.-Y. Gelderblom, H. Schlemmer, M. Demetri, G.D. Bui-Nguyen, B. McArthur, G.A. Yazji, S. Hsu, Y. Galetic, I. Rutkowski, P.